FAM78A: A Potential Drug Target Or Biomarker (G286336)

Target Name: FAM78A

NCBI ID: G286336

FAM78A

FAM78A: A Potential Drug Target Or Biomarker

The FAM78A protein is a member of the family with sequence similarity 78 (FAM78) and is expressed in various tissues and organs, including the brain, heart, and blood vessels. Its function and structure have been well-studied, and it is considered a potential drug target or biomarker for various diseases.

The FAM78A protein is a transmembrane protein that is involved in various signaling pathways in the cell. It is a member of the family with sequence similarity 78 (FAM78) and is highly conserved across various species, including humans. FAM78A is expressed in various tissues and organs, including the brain, heart, and blood vessels.

One of the key functions of FAM78A is its role in cell signaling. It is involved in various signaling pathways, including the G-protein-coupled receptor (GPCR) signaling pathway. This pathway is involved in the regulation of cellular processes such as cell growth , differentiation, and survival. FAM78A is known to be a GPCR ligand and has been shown to interact with various GPCRs, including the尾2-adrenergic receptor (尾2AR) and the GABA receptor (GABAR).

FAM78A is also involved in the regulation of inflammation and immune cell function. It is a potent inhibitor of the nuclear factor-kappa-B (NF-kappa-B) signaling pathway, which is involved in the regulation of inflammation and immune cell function. FAM78A has been shown to inhibit the activity of the NF-kappa-B pathway and has been shown to have anti-inflammatory effects.

In addition to its role in cell signaling and inflammation, FAM78A is also involved in the regulation of cellular processes such as cell adhesion and migration. It is a member of the cadherin family and has been shown to be involved in the regulation of cell adhesion and migration.

FAM78A has also been shown to be involved in the regulation of cellular processes such as cell survival and apoptosis. It is a member of the Bcl-2 family and has been shown to be involved in the regulation of cell survival and apoptosis.

Given its involvement in various signaling pathways and its potential as a drug target, FAM78A is a promising biomarker or drug target for various diseases. For example, FAM78A has been shown to be involved in the regulation of cancer cell growth and has been shown to have anti-tumor effects. It is also involved in the regulation of cardiovascular disease and has been shown to have anti-inflammatory effects.

In conclusion, the FAM78A protein is a member of the family with sequence similarity 78 and is involved in various signaling pathways in the cell. Its function and structure have been well-studied and it is considered a potential drug target or biomarker for various diseases. Further research is needed to fully understand its role in cell signaling and its potential as a drug.

Protein Name: Family With Sequence Similarity 78 Member A

The "FAM78A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM78A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets